Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization in vitro and in vivo
Background: Corneal neovascularization (CNV) is a pathological condition that can disrupt corneal transparency, thus harming visual acuity. However, there is no effective drug to treat CNV. Sunitinib (STB), a small-molecule multiple receptor tyrosine kinase inhibitor, was shown to have an effect on...
Main Authors: | Jieran Shi, Jingjing Yang, Haohang Xu, Qing Luo, Jun Sun, Yali Zhang, Zhen Liang, Ningmin Zhao, Junjie Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1157084/full |
Similar Items
-
Development of Osthole-Loaded Microemulsions as a Prospective Ocular Delivery System for the Treatment of Corneal Neovascularization: In Vitro and In Vivo Assessments
by: Yali Zhang, et al.
Published: (2023-09-01) -
Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation
by: Yu Ma, et al.
Published: (2022-12-01) -
Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization
by: Rui Zhang, et al.
Published: (2022-12-01) -
Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
by: Mohammad Nasser Hashemian, et al.
Published: (2017-01-01) -
Formulation and evaluation of ophthalmic microemulsion for enhanced topical administration of brinzolamide
by: Sehrish Zafar, et al.
Published: (2024-02-01)